Omeros Corporation Obtains Regulatory Approval to Initiate Phase 1 Clinical Trial for Lead Antibody in MASP-2 Program

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, June 13, 2013

Immunomedics, Inc. Reports Progress With Labeling Proteins, Including Antibodies, for Improved PET Imaging

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, June 12, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the...

Biotechnology Industry Organization (BIO) Statement on U.S. Supreme Court Review of Isolated DNA Patents

Thu, 13 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON--(BUSINESS WIRE)--Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on the U.S. Supreme Court's decision regarding Myriad Genetics...

Worried About Diabetes? Walk After Every Meal, George Washington University Suggests

Wed, 12 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

If you're at risk for developing type 2 diabetes, then take a 15-minute walk after every meal.

A study, out today, shows that moderately-paced walks after meals work as well at regulating overall...

Kinexus Bioinformatics Corporation Launches DrugKiNET KnowledgeBase With 105,000 Experimentally Tested Protein Kinase Drug Interactions

Wed, 12 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

New open-access website also documents over 250,000 predicted protein kinase druginteractions using proprietary algorithms

VANCOUVER...

Natural Molecular Testing Announces Beau R. Fessenden Honored as an Ernst & Young LLP Entrepreneur of the Year® Award Winner

Wed, 12 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RENTON, Wash.--(BUSINESS WIRE)--Natural Molecular Testing Corp.(Natural Molecular) announced today that Natural Molecular founder and CEO Beau R. Fessenden has been named an Ernst & Young Entrepreneur Of The...

Immunomedics, Inc. Release: 90Y-Epratuzumab Study Shows Improvement of Therapy Results Following R-CHOP

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, June 10, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the...

Immunomedics, Inc. Release: Combination of 90Y-Epratuzumab and Veltuzumab is Active in Non-Hodgkin Lymphoma

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, June 11, 2013 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU),a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the...

Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporation's xMAP Technology

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, June 11, 2013 /PRNewswire/ --Natural Molecular Testing Corporation (Natural Molecular, NMTC), a privately...

Cell Therapeutics, Inc. Announces Data Presentations at the 18th Congress of the European Hematology Association

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, June 11, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the upcoming...

Seattle Genetics, Inc. Announces Initiation of Phase 1/2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination With Bendamustine for Hodgkin Lymphoma Patients After Initial Relapse

Mon, 10 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced the initiation of a phase 1/2 clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with bendamustine for...

Immunomedics, Inc. Develops Novel Dual System for Tumor Detection and Imaging

Mon, 10 Jun 2013 12:00:00 AM GMT

Phyton Biotech, Inc. Receives CEP for Docetaxel API

Mon, 10 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, Canada--(BUSINESS WIRE)--Phyton Biotech, a global supplier of high quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European...

University of Washington Spinout Wins FDA OK for Heartbeat Monitor

Fri, 07 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Cardiac Insight Receives 510(k) Clearance for Wearable Monitor for Outpatient ECG Monitoring

Bellevue,WA (PRWEB) June 05, 2013- Cardiac Insight, Inc., a company focused...

Vanda Pharmaceuticals, Inc. Presents Data From Tasimelteon Phase III Studies in Non-24-Hour Disorder

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, June 5, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) presented additional entrainment...

FEI Company and University of Oklahoma Begin Collaboration Research Agreement for Understanding and Developing Unconventional Oil and Gas Reservoirs

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HILLSBORO, Ore., June 6, 2013 (GLOBE NEWSWIRE) -- FEI (Nasdaq:FEIC) and University of Oklahoma (OU) have commenced a research collaboration agreement to establish an oil and gas center of excellence, the "FEI...

FEI Company Increases Cash Dividend by 50%

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HILLSBORO, Ore., June 6, 2013 (GLOBE NEWSWIRE) -- FEI Company (Nasdaq:FEIC) announced that its board of directors has approved an increase in the quarterly cash dividends to its shareholders from $.08 to $...

FEI Company Helios 1200AT DualBeam System Accelerates Process Development and Ram

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HILLSBORO, Ore., June 6, 2013 (GLOBE NEWSWIRE) -- FEI (Nasdaq:FEIC) today released the Helios NanoLab 1200AT, the newest generation of its full-wafer DualBeam analysis systems. The addition of an optional...

Researchers Reveal Malaria's Deadly Grip: University of Copenhagen and Collaborators Study

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, WA Researchers at the University of Copenhagen, in collaboration with Seattle Biomedical Research Institute, the University of Oxford, NIMR Tanzania and Retrogenix LTD, have identified how malaria...

Peter J. Carbonaro Joins Atossa Genetics, Inc. as Senior Vice President of Operations

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, WA--(Marketwired - June 05, 2013) -

Highlighted Links

Results of New Analysis Support Use of NanoString Technologies Inc.???s Prosigna™ Assay to Help Identify Node-Positive Early-Stage Breast Cancer Patients at Low Risk of Recurrence

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE & CHICAGO--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced new results from...

Galena Biopharma Provides Product Pipeline Update at the American Society of Clinical Oncology 2013 Annual Meeting

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAKE OSWEGO, Ore., June 3, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance...

VentiRx Pharmaceuticals, Inc. Release: Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 American Society of Clinical Oncology Annual Meeting Shows Early Activity in Ovarian Cancer

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, June 3, 2013 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc. in collaboration with the Gynecologic Oncology Group...

NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna??? Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

Mon, 03 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer...

QIAGEN Inc. Picks Up New Cancer Biomarkers in Two Deals

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Qiagen is making two agreements to add new biomarkers involving glioblastoma, lymphoma, and other cancers to its portfolio of potential companion diagnostics. The first agreement, a glioblastoma project, is...

Vanda Pharmaceuticals, Inc. Announces Submission to FDA of a New Drug Application for Tasimelteon for the Treatment of Non-24-Hour Disorder in the Totally Blind

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, May 31, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced the submission...

Omeros Corporation Reports Positive Results From OMS824 Positron Emission Tomography Clinical Trial

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 31, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive results from its Phase...

Dendreon Corporation Announces Presentation of PROVENGE?? (sipuleucel-T) Data at the 2013 American Society of Clinical Oncology Annual Meeting

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Dendreon Corporation (NASDAQ: DNDN) announced today that four abstracts featuring PROVENGE (sipuleucel-T) data from ongoing Phase II sequencing studies and the PROCEED registry, and two abstracts highlighting...

Early Brain Responses to Words Predict Developmental Outcomes in Children With Autism, University of Washington Study

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The pattern of brain responses to words in 2-year-old children with autism spectrum disorder predicted the youngsters linguistic, cognitive and adaptive skills at ages 4 and 6, according to a new study. The...

Oncothyreon Inc. Announces $10 Million Registered Direct Offering to

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 30, 2013 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced that it has agreed...

Galena Biopharma to Present at the Jefferies and Co. 2013 Global Healthcare Conference

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAKE OSWEGO, Ore., May 30, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance...

Mirador Biomedical Study: Spend $35 on Our Device & Save $116

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Seattle-based Mirador Biomedical is trying to sell hospitals a little digital device for about $35 apiece, in hopes of preventing a rare and disastrous thing from happening to patients. Now the company has gathered...

Agere Augments Leadership With Pharmaceutical Manufacturing and Supply Chain Expert

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BEND, Ore.--(BUSINESS WIRE)--Agere Pharmaceuticals, Inc., a leading oral bioavailability contract development and manufacturing organization (CDMO), announced today that Mr. Michael R. Deperro has joined the...

Seattle Genetics, Inc. to Present at Upcoming Investor Conferences

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the following upcoming investor conferences. The presentations will be webcast live and available for replay from Seattle...

Oncothyreon Inc. to Present at Jefferies and Co. 2013 Global Healthcare Conference

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 29, 2013 /PRNewswire/ -Oncothyreon Inc. (Nasdaq: ONTY) announced today that

Omeros Corporation Files Clinical Trial Application for Lead Antibody in MASP-2 Program

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, Wash., May 28, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that it has filed a...

University of California, Irvine Researchers Demonstrate Drug Candidate ShK-186, Derived From Sea Anemone Venom, Effective in Anti-Obesity Studies

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINE, Calif. & SEATTLE--(BUSINESS WIRE)--Scientists at UC Irvine reported this week that a synthetic compound ShK-186, originally derived from a sea anemone toxin, has been found to enhance metabolic activity...

Neovasc Inc. Reports Financial Results for First Quarter of 2013

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, May 28, 2013 --Increased Year-over-Year Revenues by 17%, Driven by Growth in Contract Manufacturing and Consulting Services to Transcatheter Heart Valve Customers-- --Completed Patient Enrollment...

OncoGenex Pharmaceuticals Inc. to Present at Upcoming Investor Conference

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, WA and VANCOUVER, May 28, 2013 /PRNewswire/ - OncoGenex Pharmaceuticals...

DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology Annual Meeting

Tue, 28 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia and MENLO PARK, Calif., May 28, 2013 /PRNewswire/ --

Vanda Pharmaceuticals, Inc. Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, May 23, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the...

Cardeas Pharma Snags $34 Million for Antibiotic Against Hospital Infections

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Seattle-based Cardeas Pharma just raised a lot more cash to fight a big problem that hospitals wrestle with every day, and which theyd rather not say much about publicly. Cardeas, the startup led by prolific...

OncoGenex Pharmaceuticals Inc. Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination With Chemotherapy in Advanced Squamous Cell Lung Cancer

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash. and VANCOUVER, British Columbia, May 23, 2013 /PRNewswire/ -- OncoGenex...

Omeros Corporation Release: Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 23, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that its Investigational...

Kona Medical Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BELLEVUE, Wash. & MENLO PARK, Calif.--(BUSINESS WIRE)--Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR...

BioLife Solutions, Inc. Announces Presentation at

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash., May 23, 2013 /PRNewswire/ -- BioLife Solutions...

Galena Biopharma to Present at the Conference

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LAKE OSWEGO, Ore., May 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance...

Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc Inc.'s Tiara(TM) Transcatheter Mitral Valve into Human Trials

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

-Longer-Term Animal Data Suggests Tiara Device for the Transcatheter Treatment of Mitral Valve Disease Appears Safe and Well Tolerated

TSX Venture Exchange...

Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at Meeting in Paris

Thu, 23 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Kona Medical announced that three and six month results from the WAVE I study were presented today at the late-breaking clinical trials session of EuroPCR in Paris by Robert Whitbourn, MD, of St. Vincents Hospital...

Atossa Genetics, Inc. to Exhibit Its ForeCYTE Breast Health Test at the 2013 American Society of Clinical Oncology Annual Meeting

Thu, 23 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, WA--(Marketwired - May 23, 2013) -
Highlighted Links

Omeros Corporation to Present at Two Upcoming Conferences

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 22, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering...

OncoGenex Pharmaceuticals Inc. Announces Multiple 'Trials in Progress' Presentations at the 2013 American Society of Clinical Oncology Annual Meeting

Wed, 22 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash. and VANCOUVER, British Columbia, May 22, 2013 /PRNewswire/ -- OncoGenex...

NanoString Technologies Inc. Maneuvers in Line for $86 Million IPO

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NanoString Technologies Files Registration Statement with the Securities and Exchange Commission for an Initial Public Offering

SEATTLE--(BUSINESS WIRE)--May 20, 201...

IsoRay Announces a New International Distributor for Greece

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RICHLAND, Wash., May 21, 2013 /PRNewswire/ -- IsoRay, Inc. (AMEX: ISR), (

Registry Data Presented at Confirms the Neovasc Inc. Reducer??? Improves Cardiovascular Parameters in Refractory Angina Patients

Tue, 21 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

-Initial Data from Patient Registries Shows the Reducer Significantly Improves Angina Scores at Six Months Post-Implantation-
TSX Venture Exchange: NVC ...

Roche and Team Up to Launch Successful Startups in the Bay Area

Mon, 20 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Roche and QB3 Team Up to Launch Successful Startups in the Bay Area

Basel, Switzerland and Seattle, WA, USA May 16, 2013 -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and the...

EDAP TMS S.A.'s Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study

Mon, 20 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LYON, France, May 20, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today new long term data demonstrating high rates of both cancer-specific and...

RS Medical Reaches Settlement on Investigation

Mon, 20 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, Wash.--(BUSINESS WIRE)--International Rehabilitative Sciences, Inc., d/b/a RS Medical, today announced it has reached a settlement with the United States Department of Justice addressing actions taken...

Tekmira Pharmaceuticals Corporation Announces Election of Directors

Mon, 20 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, May 17, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that the nominees...

Pacific Biomarkers and Clinigene International to Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference

Mon, 20 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 20, 2013 /PRNewswire/ -- Pacific Biomarkers and Clinigene International are set to unveil their collaborative laboratory solutions for...

National Institutes of Health (NIH) Saves Lives: Fred Hutchinson Cancer Research Center Calls on Congress to Restore Full Funding

Thu, 16 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, May 15, 2013 /PRNewswire/ -- Fred Hutchinson Cancer...

DelMar Pharmaceuticals Provides Corporate Update for the Quarter Ended March 31, 2013

Thu, 16 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia and MENLO PARK, Calif., May 16, 2013 /PRNewswire/ -- DelMar...

Tekmira Pharmaceuticals Corporation Presents LNP Technology Innovations at Scientific Symposium

Thu, 16 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, May 15, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that data demonstrating...

NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna??? Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

Thu, 16 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer...

Plandai Biotechnology, Inc. Announces Positive Anti-Malaria Test Results Using Phytofare™ Extract

Wed, 15 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 15, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable...

Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces First Quarter 2013 Results

Wed, 15 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

VANCOUVER, British Columbia, May 14, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced its financial...

Cell Therapeutics, Inc. to Present at Upcoming Investor Conferences

Wed, 15 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, May 15, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced...

Seattle Genetics, Inc. Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by the FDA

Tue, 14 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplement to the Biologics License Application...

CMC Biologics and RuiYi (formerly Anaphore) Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody

Tue, 14 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SEATTLE, COPENHAGEN, Denmark and SHANGHAI, May 14, 201...

Astellas Pharma Inc. Joins the

Tue, 14 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, May 14, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that...

Physio-Control Introduces TrueCPR Coaching Device to Optimize Manual CPR Performance

Tue, 14 May 2013 12:00:00 AM GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Physio-Control, a leading provider of emergency medical response technologies worldwide, today announced availability of the TrueCPR coaching device, a key part of Physio-Controls cardiopulmonary resuscitation...

BioSpace.com Featured News

Mirabilis Medica Restructures, Raises $10 Million Series A-1 Financing

Vestibular Prosthesis to Help Restore Balance for Those With Meniere's Disease, University of Washington Study

Halifax Teams With Management to Acquire Envision Pharma, Inc.

BoXin LaiTe Biotechnology and University of British Columbia Sign MOU

Cell Therapeutics, Inc. Release: New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment

Cell Therapeutics, Inc. Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients With Myelofibrosis

Cell Therapeutics, Inc. to Join Russell 3000® and Russell Global Indexes

BIOTRONIK SE & Co.KG Showcases DX System at Breakthroughs Conference and Exhibition

Baldness Drug Curbs Men's Interest in Alcohol, George Washington University Study Suggests

Omeros Corporation Obtains Regulatory Approval to Initiate Phase 1 Clinical Trial for Lead Antibody in MASP-2 Program

Immunomedics, Inc. Reports Progress With Labeling Proteins, Including Antibodies, for Improved PET Imaging

Biotechnology Industry Organization (BIO) Statement on U.S. Supreme Court Review of Isolated DNA Patents

Worried About Diabetes? Walk After Every Meal, George Washington University Suggests

Kinexus Bioinformatics Corporation Launches DrugKiNET KnowledgeBase With 105,000 Experimentally Tested Protein Kinase Drug Interactions

Natural Molecular Testing Announces Beau R. Fessenden Honored as an Ernst & Young LLP Entrepreneur of the Year® Award Winner

Immunomedics, Inc. Release: 90Y-Epratuzumab Study Shows Improvement of Therapy Results Following R-CHOP

Immunomedics, Inc. Release: Combination of 90Y-Epratuzumab and Veltuzumab is Active in Non-Hodgkin Lymphoma

Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporation's xMAP Technology

Cell Therapeutics, Inc. Announces Data Presentations at the 18th Congress of the European Hematology Association

Seattle Genetics, Inc. Announces Initiation of Phase 1/2 Trial of ADCETRIS® (Brentuximab Vedotin) in Combination With Bendamustine for Hodgkin Lymphoma Patients After Initial Relapse

Immunomedics, Inc. Develops Novel Dual System for Tumor Detection and Imaging

Phyton Biotech, Inc. Receives CEP for Docetaxel API

University of Washington Spinout Wins FDA OK for Heartbeat Monitor

Vanda Pharmaceuticals, Inc. Presents Data From Tasimelteon Phase III Studies in Non-24-Hour Disorder

FEI Company and University of Oklahoma Begin Collaboration Research Agreement for Understanding and Developing Unconventional Oil and Gas Reservoirs

FEI Company Increases Cash Dividend by 50%

FEI Company Helios 1200AT DualBeam System Accelerates Process Development and Ram

Researchers Reveal Malaria's Deadly Grip: University of Copenhagen and Collaborators Study

Peter J. Carbonaro Joins Atossa Genetics, Inc. as Senior Vice President of Operations

Results of New Analysis Support Use of NanoString Technologies Inc.???s Prosigna™ Assay to Help Identify Node-Positive Early-Stage Breast Cancer Patients at Low Risk of Recurrence

Galena Biopharma Provides Product Pipeline Update at the American Society of Clinical Oncology 2013 Annual Meeting

VentiRx Pharmaceuticals, Inc. Release: Preclinical and Phase 1 Data of VTX-2337 Presented at 2013 American Society of Clinical Oncology Annual Meeting Shows Early Activity in Ovarian Cancer

NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna??? Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

QIAGEN Inc. Picks Up New Cancer Biomarkers in Two Deals

Vanda Pharmaceuticals, Inc. Announces Submission to FDA of a New Drug Application for Tasimelteon for the Treatment of Non-24-Hour Disorder in the Totally Blind

Omeros Corporation Reports Positive Results From OMS824 Positron Emission Tomography Clinical Trial

Dendreon Corporation Announces Presentation of PROVENGE?? (sipuleucel-T) Data at the 2013 American Society of Clinical Oncology Annual Meeting

Early Brain Responses to Words Predict Developmental Outcomes in Children With Autism, University of Washington Study

Oncothyreon Inc. Announces $10 Million Registered Direct Offering to

Galena Biopharma to Present at the Jefferies and Co. 2013 Global Healthcare Conference

Mirador Biomedical Study: Spend $35 on Our Device & Save $116

Agere Augments Leadership With Pharmaceutical Manufacturing and Supply Chain Expert

Seattle Genetics, Inc. to Present at Upcoming Investor Conferences

Oncothyreon Inc. to Present at Jefferies and Co. 2013 Global Healthcare Conference

Omeros Corporation Files Clinical Trial Application for Lead Antibody in MASP-2 Program

University of California, Irvine Researchers Demonstrate Drug Candidate ShK-186, Derived From Sea Anemone Venom, Effective in Anti-Obesity Studies

Neovasc Inc. Reports Financial Results for First Quarter of 2013

OncoGenex Pharmaceuticals Inc. to Present at Upcoming Investor Conference

DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology Annual Meeting

Vanda Pharmaceuticals, Inc. Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland

Cardeas Pharma Snags $34 Million for Antibiotic Against Hospital Infections

OncoGenex Pharmaceuticals Inc. Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination With Chemotherapy in Advanced Squamous Cell Lung Cancer

Omeros Corporation Release: Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease

Kona Medical Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris

BioLife Solutions, Inc. Announces Presentation at

Galena Biopharma to Present at the Conference

Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc Inc.'s Tiara(TM) Transcatheter Mitral Valve into Human Trials

Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at Meeting in Paris

Atossa Genetics, Inc. to Exhibit Its ForeCYTE Breast Health Test at the 2013 American Society of Clinical Oncology Annual Meeting

Omeros Corporation to Present at Two Upcoming Conferences

OncoGenex Pharmaceuticals Inc. Announces Multiple 'Trials in Progress' Presentations at the 2013 American Society of Clinical Oncology Annual Meeting

NanoString Technologies Inc. Maneuvers in Line for $86 Million IPO

IsoRay Announces a New International Distributor for Greece

Registry Data Presented at Confirms the Neovasc Inc. Reducer??? Improves Cardiovascular Parameters in Refractory Angina Patients

Roche and Team Up to Launch Successful Startups in the Bay Area

EDAP TMS S.A.'s Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study

RS Medical Reaches Settlement on Investigation

Tekmira Pharmaceuticals Corporation Announces Election of Directors

Pacific Biomarkers and Clinigene International to Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference

National Institutes of Health (NIH) Saves Lives: Fred Hutchinson Cancer Research Center Calls on Congress to Restore Full Funding

DelMar Pharmaceuticals Provides Corporate Update for the Quarter Ended March 31, 2013

Tekmira Pharmaceuticals Corporation Presents LNP Technology Innovations at Scientific Symposium

NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna??? Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

Plandai Biotechnology, Inc. Announces Positive Anti-Malaria Test Results Using Phytofare™ Extract

Tekmira Pharmaceuticals Corporation Provides Corporate Update and Announces First Quarter 2013 Results

Cell Therapeutics, Inc. to Present at Upcoming Investor Conferences

Seattle Genetics, Inc. Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by the FDA

CMC Biologics and RuiYi (formerly Anaphore) Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody

Astellas Pharma Inc. Joins the